ProfileGDS5678 / 1449105_at
TitleAnti-VEGF and Anti-Notch treatment effect on U87 glioblastoma xenograft tumors [Mouse430_2]
OrganismMus musculus


control bevacizumab dibenzazepine GSM967852 GSM967853 GSM967854 GSM967855 GSM967856 GSM967862 GSM967863 GSM967864 GSM967865 GSM967857 GSM967858 GSM967859 GSM967860 GSM967861 23% 30% 25% 57% 26% 22% 23% 25% 34% 25% 24% 25% 25% 24% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM967852U87-EV human glioblastoma xenograft - Control 12.5728723
GSM967853U87-EV human glioblastoma xenograft - Control 22.6893530
GSM967854U87-EV human glioblastoma xenograft - Control 32.5695625
GSM967855U87-EV human glioblastoma xenograft - Control 43.4210257
GSM967856U87-EV human glioblastoma xenograft - Control 52.5508726
GSM967862U87-EV human glioblastoma xenograft - Bevacizumab treated 12.5822122
GSM967863U87-EV human glioblastoma xenograft - Bevacizumab treated 22.5655323
GSM967864U87-EV human glioblastoma xenograft - Bevacizumab treated 32.5556525
GSM967865U87-EV human glioblastoma xenograft - Bevacizumab treated 42.745834
GSM967857U87-EV human glioblastoma xenograft - dibenzazepine treated 12.5692225
GSM967858U87-EV human glioblastoma xenograft - dibenzazepine treated 22.5485524
GSM967859U87-EV human glioblastoma xenograft - dibenzazepine treated 32.5602425
GSM967860U87-EV human glioblastoma xenograft - dibenzazepine treated 42.5687725
GSM967861U87-EV human glioblastoma xenograft - dibenzazepine treated 52.5578624